Notes Payable (Details Narrative) |
1 Months Ended | 3 Months Ended | 9 Months Ended | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jul. 12, 2017
USD ($)
$ / shares
shares
|
Mar. 06, 2017
USD ($)
|
Oct. 11, 2016
USD ($)
shares
|
Sep. 14, 2016 |
Dec. 01, 2015
USD ($)
|
Nov. 12, 2015
USD ($)
|
Aug. 01, 2015
USD ($)
|
May 15, 2015
USD ($)
|
Mar. 20, 2017
USD ($)
|
Jan. 31, 2017 |
Dec. 31, 2016
USD ($)
|
Sep. 30, 2016
USD ($)
|
Aug. 31, 2016
USD ($)
Number
|
Jul. 31, 2016
USD ($)
|
May 31, 2016
USD ($)
|
Mar. 31, 2016
USD ($)
|
Feb. 29, 2016
USD ($)
|
Dec. 30, 2015
USD ($)
|
Sep. 30, 2017
USD ($)
|
Sep. 30, 2016
USD ($)
|
Sep. 30, 2017
USD ($)
|
Sep. 30, 2016
USD ($)
|
Jun. 30, 2017
USD ($)
|
Jun. 30, 2016
USD ($)
|
|
| Risk free interest rate | 1.53% | 1.52% | ||||||||||||||||||||||
| Expected life | 5 years | 5 years 6 months | ||||||||||||||||||||||
| Expected volatility | 45.54% | 95.24% | ||||||||||||||||||||||
| Expected dividend yield | 0.00% | 0.00% | ||||||||||||||||||||||
| Amount of related party debt satisfied by Watermark | $ 41,500 | |||||||||||||||||||||||
| Interest paid | 73,523 | 10,050 | ||||||||||||||||||||||
| Loss on extinguishment of debt | $ 2,072,365 | 2,072,365 | ||||||||||||||||||||||
| Zika Diagnostics Inc [Member] | ||||||||||||||||||||||||
| Common stock shares issuable by Watermark, value | $ 1,050,000 | |||||||||||||||||||||||
| Legends Capital Group, LLC Convertible Note [Member] | ||||||||||||||||||||||||
| Convertible promissory note | $ 100,000 | |||||||||||||||||||||||
| Interest rate | 8.50% | |||||||||||||||||||||||
| Due date | Sep. 30, 2017 | |||||||||||||||||||||||
| Terms of conversion feature | The note contained a conversion feature allowing the principal and any unpaid accrued interest to be converted into common shares of the company at a rate of $11.00 or 20% less than the price of the anticipated Initial Public Offering, whichever is less, per share at the discretion of the note holder. | |||||||||||||||||||||||
| Convertible debt, description | Legends Capital Group is a 12% shareholder of the Company | |||||||||||||||||||||||
| Debt conversion, principal | $ 100,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 14,143 | |||||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 23,780 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 4.80 | |||||||||||||||||||||||
| Conversion price, description | lesser of $16.50 | |||||||||||||||||||||||
| Loss on extinguishment of debt | $ 28,614 | |||||||||||||||||||||||
| Clavo Rico Promissory Note [Member] | ||||||||||||||||||||||||
| Convertible promissory note | $ 10,000 | |||||||||||||||||||||||
| Interest rate | 12.00% | |||||||||||||||||||||||
| Due date | Sep. 30, 2017 | |||||||||||||||||||||||
| Terms of conversion feature | we amended the note to provide that the principal and interest on the note would be convertible to shares of common stock at a conversion rate of $8.25 per share or a discount of 30% to the price of an IPO if the Company were to file a Registration Statement. | |||||||||||||||||||||||
| Debt conversion, principal | 100,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 1,660 | |||||||||||||||||||||||
| Interest expense | 36 | 302 | $ 631 | $ 727 | ||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 2,776 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 4.20 | |||||||||||||||||||||||
| Loss on extinguishment of debt | $ 4,996 | |||||||||||||||||||||||
| Warrant [Member] | ||||||||||||||||||||||||
| Risk free interest rate | 1.89% | 1.96% | ||||||||||||||||||||||
| Expected life | 4 years 8 months 12 days | 5 years | ||||||||||||||||||||||
| Expected volatility | 46.80% | 80.49% | ||||||||||||||||||||||
| Expected dividend yield | 0.00% | 0.00% | ||||||||||||||||||||||
| Warrant [Member] | Legends Capital Group, LLC Convertible Note [Member] | ||||||||||||||||||||||||
| Due date | Nov. 12, 2020 | |||||||||||||||||||||||
| Debt discount | $ 665 | |||||||||||||||||||||||
| Accretion of note discount included in interest expense | 11 | 89 | $ 186 | $ 265 | ||||||||||||||||||||
| Interest expense | 260 | 2,125 | 4,510 | 6,375 | ||||||||||||||||||||
| Common stock shares issuable upon conversion of convertible securities | shares | 4,545 | |||||||||||||||||||||||
| Risk free interest rate | 1.67% | |||||||||||||||||||||||
| Expected life | 5 years | |||||||||||||||||||||||
| Expected volatility | 97.71% | |||||||||||||||||||||||
| Expected dividend yield | 0.00% | |||||||||||||||||||||||
| Share price | $ / shares | $ 0.638 | |||||||||||||||||||||||
| Bridge Notes Payable [Member] | ||||||||||||||||||||||||
| Convertible promissory note | $ 1,683,500 | |||||||||||||||||||||||
| Interest rate | 15.00% | |||||||||||||||||||||||
| Due date | Jun. 12, 2017 | Jun. 30, 2017 | ||||||||||||||||||||||
| Terms of conversion feature | The notes provided that the principal and interest on the notes would be convertible to shares of common stock at a conversion rate of the lesser of $8.25 per share or seventy percent (70%) of the initial public offering (“IPO”) price per share | |||||||||||||||||||||||
| Convertible debt, description | Company entered into convertible promissory notes with six individuals and five companies, in the aggregate principal amount of $1,683,500 which consisted of (a) $1,100,000 of new investor funding and (b) $583,500 representing the satisfaction of the $500,000 note principal plus $83,500 of accrued interest on the Beaufort Capital Partners, LLC Convertible Note | |||||||||||||||||||||||
| Debt conversion, principal | $ 1,683,500 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 73,651 | |||||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 418,370 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 4.20 | |||||||||||||||||||||||
| Proceeds from convertible debt, net of commissions | $ 1,041,000 | |||||||||||||||||||||||
| Amount of commissions withheld | $ 59,000 | |||||||||||||||||||||||
| Description for proceeds from convertible debt | The Company (i) received $1,041,000 in cash (net of $59,000 in commissions withheld) and, (ii) converted $583,500 of principal and interest from the Beaufort Capital Partners, LLC Convertible Note mentioned above | |||||||||||||||||||||||
| Interest paid | $ 23,055 | |||||||||||||||||||||||
| Loss on extinguishment of debt | $ 1,403,241 | |||||||||||||||||||||||
| Bridge Notes Payable [Member] | New investor funding [Member] | ||||||||||||||||||||||||
| Convertible promissory note | $ 1,100,000 | |||||||||||||||||||||||
| Bridge Notes Payable [Member] | Warrant One [Member] | ||||||||||||||||||||||||
| Due date | Dec. 29, 2021 | |||||||||||||||||||||||
| Debt conversion, principal | $ 578,706 | |||||||||||||||||||||||
| Common stock shares issuable upon conversion of convertible securities | shares | 211,740 | |||||||||||||||||||||||
| Risk free interest rate | 1.90% | |||||||||||||||||||||||
| Expected life | 4 years 6 months | |||||||||||||||||||||||
| Expected volatility | 46.41% | |||||||||||||||||||||||
| Expected dividend yield | 0.00% | |||||||||||||||||||||||
| Share price | $ / shares | $ 6.00 | |||||||||||||||||||||||
| Description for debt default | the Company agreed to increase the number of warrants from 50% of the shares issuable to the note holders upon conversion to 75% of the shares issuable to the note holders upon conversion | |||||||||||||||||||||||
| Bridge Notes Payable [Member] | Warrant [Member] | ||||||||||||||||||||||||
| Due date | Dec. 31, 2021 | |||||||||||||||||||||||
| Payments for finder's fee | $ 59,000 | |||||||||||||||||||||||
| Debt discount | $ 11,914 | |||||||||||||||||||||||
| Accretion of note discount included in interest expense | 79,696 | |||||||||||||||||||||||
| Interest expense | 7,610 | 132,691 | ||||||||||||||||||||||
| Common stock shares issuable upon conversion of convertible securities | shares | 102,039 | |||||||||||||||||||||||
| Conversion price, description | price of eighty-five percent (85%) of the Company’s IPO price per share | |||||||||||||||||||||||
| Risk free interest rate | 1.96% | |||||||||||||||||||||||
| Expected life | 5 years | |||||||||||||||||||||||
| Expected volatility | 80.49% | |||||||||||||||||||||||
| Expected dividend yield | 0.00% | |||||||||||||||||||||||
| Share price | $ / shares | $ 0.638 | |||||||||||||||||||||||
| Description for debt default | Upon any default of the notes for non-payment, any bankruptcy event or breach of the note or other transaction documents, the Company may be liable to pay a default redemption amount equal to 130% of the amount due under the note and deliver an additional warrant to purchase 50% of the common stock issuable upon conversion of the notes | |||||||||||||||||||||||
| Loan preparation fees | $ 15,000 | |||||||||||||||||||||||
| Zika Diagnostics, Inc. Note Payable [Member] | License agreement [Member] | ||||||||||||||||||||||||
| Convertible promissory note | $ 445,000 | $ 445,000 | ||||||||||||||||||||||
| Interest rate | 12.00% | |||||||||||||||||||||||
| Due date | Dec. 31, 2020 | Sep. 30, 2017 | ||||||||||||||||||||||
| Debt conversion, principal | 445,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 17,800 | |||||||||||||||||||||||
| Interest expense | 2,670 | 17,800 | ||||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 77,133 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 6.00 | |||||||||||||||||||||||
| Royalty receivable | $ 500,000 | |||||||||||||||||||||||
| Royalty, percentage | 10.00% | |||||||||||||||||||||||
| Equity method investment, shares to be acquired under agreement | shares | 3,600,000 | |||||||||||||||||||||||
| Equity method investment, value of shares to be acquired under agreement | $ 55,000 | |||||||||||||||||||||||
| Royalty revenue | $ 500,000 | |||||||||||||||||||||||
| Common stock shares returned, value | $ 55,000 | |||||||||||||||||||||||
| Loss on extinguishment of debt | $ 2 | |||||||||||||||||||||||
| Related note [Member] | Zika Diagnostics Inc [Member] | ||||||||||||||||||||||||
| Amount of related party debt satisfied by Watermark | $ 172,000 | |||||||||||||||||||||||
| Litigation, damages sought by P&G Holdings | P&G Holdings filed a lawsuit in Federal District Court in New York demanding payment of the Related Note, all accrued interest thereon and attorney’s fees and that stock be issued such that P&G Holdings would own 80% of the issued and outstanding shares of stock of Watermark | |||||||||||||||||||||||
| December 2016 Notes Payable [Member] | ||||||||||||||||||||||||
| Convertible promissory note | $ 105,000 | |||||||||||||||||||||||
| Interest rate | 10.00% | |||||||||||||||||||||||
| Due date | Dec. 31, 2017 | |||||||||||||||||||||||
| Terms of conversion feature | The notes provide that the principal and interest on the notes would be convertible to shares of common stock at a conversion rate of $8.25 per share or seventy percent (70%) of the anticipated initial public offering (“IPO”) price per share | |||||||||||||||||||||||
| Convertible debt, description | Company entered into convertible promissory notes with two individuals and one company | |||||||||||||||||||||||
| Debt conversion, principal | 105,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 6,333 | |||||||||||||||||||||||
| Interest expense | 321 | 5,571 | ||||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 26,508 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 4.20 | |||||||||||||||||||||||
| Loss on extinguishment of debt | $ 47,715 | |||||||||||||||||||||||
| Commercial Paper [Member] | Robert Salna [Member] | ||||||||||||||||||||||||
| Convertible promissory note | $ 200,000 | $ 200,000 | $ 200,000 | |||||||||||||||||||||
| Interest rate | 10.00% | 10.00% | 10.00% | |||||||||||||||||||||
| Due date | Dec. 31, 2017 | |||||||||||||||||||||||
| Terms of conversion feature | The note provides that the principal and interest on the note would be convertible to shares of common stock at a conversion rate of $8.25 per share or a discount of 15% to the conversion price of a bridge financing anticipated closing prior to filing a Registration Statement, which bridge financing, was completed on December 12, 2016 | |||||||||||||||||||||||
| Debt conversion, principal | 200,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 16,833 | |||||||||||||||||||||||
| Payments for finder's fee | $ 10,000 | |||||||||||||||||||||||
| Accretion of note discount included in interest expense | 228 | $ 519 | 3,983 | $ 519 | ||||||||||||||||||||
| Interest expense | 611 | 1,333 | 10,500 | 1,333 | ||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 60,738 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 3.57 | |||||||||||||||||||||||
| Loss on extinguishment of debt | $ 151,184 | |||||||||||||||||||||||
| Commercial Paper [Member] | Pine Valley Investments, LLC [Member] | Revolving Credit Facility [Member] | ||||||||||||||||||||||||
| Interest rate | 12.00% | |||||||||||||||||||||||
| Due date | Sep. 30, 2017 | |||||||||||||||||||||||
| Debt conversion, principal | 86,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 9,626 | |||||||||||||||||||||||
| Interest expense | 220 | 1,843 | 3,845 | 3,984 | ||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 22,768 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 4.20 | |||||||||||||||||||||||
| Maximum borrowing capacity | $ 100,000 | |||||||||||||||||||||||
| Line of credit facility amount outstanding | $ 86,000 | 86,000 | 86,000 | |||||||||||||||||||||
| Loss on extinguishment of debt | $ 40,982 | |||||||||||||||||||||||
| Commercial Paper [Member] | Co Diagnostics, Ltd [Member] | Revolving Credit Facility [Member] | ||||||||||||||||||||||||
| Interest rate | 12.00% | |||||||||||||||||||||||
| Due date | Sep. 30, 2017 | |||||||||||||||||||||||
| Convertible debt, description | greater than 20% shareholder | |||||||||||||||||||||||
| Debt conversion, principal | 609,940 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 112,633 | |||||||||||||||||||||||
| Interest expense | 2,206 | 17,432 | 38,501 | 44,923 | ||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 172,041 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 4.20 | |||||||||||||||||||||||
| Maximum borrowing capacity | $ 750,000 | |||||||||||||||||||||||
| Line of credit facility amount outstanding | 609,940 | 609,940 | ||||||||||||||||||||||
| Loss on extinguishment of debt | $ 309,673 | |||||||||||||||||||||||
| Commercial Paper [Member] | Legends Capital Group, LLC [Member] | Revolving Credit Facility [Member] | ||||||||||||||||||||||||
| Interest rate | 12.00% | |||||||||||||||||||||||
| Due date | Sep. 30, 2017 | |||||||||||||||||||||||
| Terms of conversion feature | the Company amended the note to provide that the principal and interest on the note would be convertible to shares of common stock at a conversion rate of $8.25 per share or a discount of 30% to the price of an IPO if we were to file a Registration Statement. | |||||||||||||||||||||||
| Debt conversion, principal | 10,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 6,112 | |||||||||||||||||||||||
| Interest expense | 36 | 2,213 | 631 | 3,475 | ||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 3,836 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 4.20 | |||||||||||||||||||||||
| Maximum borrowing capacity | $ 100,000 | |||||||||||||||||||||||
| Line of credit facility amount outstanding | 10,000 | 10,000 | ||||||||||||||||||||||
| Loss on extinguishment of debt | $ 6,904 | |||||||||||||||||||||||
| Commercial Paper [Member] | Hamilton Mining Resources [Member] | Revolving Credit Facility [Member] | ||||||||||||||||||||||||
| Interest rate | 12.00% | |||||||||||||||||||||||
| Due date | Sep. 30, 2017 | |||||||||||||||||||||||
| Terms of conversion feature | the Company amended the note to provide that the principal and interest on the note would be convertible to shares of common stock at a conversion rate of $8.25 per share or a discount of 30% to the price of an IPO if we were to file a Registration Statement. | |||||||||||||||||||||||
| Debt conversion, principal | 66,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 8,726 | |||||||||||||||||||||||
| Interest expense | 242 | 1,824 | 4,202 | 2,544 | ||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 17,792 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 4.20 | |||||||||||||||||||||||
| Maximum borrowing capacity | $ 75,000 | |||||||||||||||||||||||
| Line of credit facility amount outstanding | $ 66,000 | $ 66,000 | ||||||||||||||||||||||
| Loss on extinguishment of debt | $ 32,026 | |||||||||||||||||||||||
| Commercial Paper [Member] | Machan 1988 Property Trust [Member] | Revolving Credit Facility [Member] | ||||||||||||||||||||||||
| Interest rate | 12.00% | |||||||||||||||||||||||
| Terms of conversion feature | the Company amended the note to provide that the principal and interest on the note would be convertible to shares of common stock at a conversion rate of $8.25 per share or a discount of 30% to the price of an IPO if we were to file a Registration Statement before December 31, 2016. | |||||||||||||||||||||||
| Interest expense | 1,273 | 913 | 1,625 | |||||||||||||||||||||
| Maximum borrowing capacity | $ 50,000 | |||||||||||||||||||||||
| Line of credit facility amount outstanding | $ 41,500 | |||||||||||||||||||||||
| Line of credit facility retired principal, amount | $ 41,500 | |||||||||||||||||||||||
| Convertible Note [Member] | R. Phillip Zobrist [Member] | ||||||||||||||||||||||||
| Convertible promissory note | $ 100,000 | |||||||||||||||||||||||
| Interest rate | 8.50% | |||||||||||||||||||||||
| Due date | Sep. 30, 2017 | |||||||||||||||||||||||
| Terms of conversion feature | The note contains a conversion feature allowing the principal and any unpaid accrued interest to be converted into common shares of the company at a rate of $11.00 or 20% less than the price of the anticipated Initial Public Offering, whichever is less, per share at the discretion of the note holder | |||||||||||||||||||||||
| Debt conversion, principal | 100,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 13,718 | |||||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 23,691 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 4.80 | |||||||||||||||||||||||
| Convertible Note [Member] | Legends Capital Opportunity Fund, LLC [Member] | ||||||||||||||||||||||||
| Convertible promissory note | $ 25,000 | |||||||||||||||||||||||
| Number of convertible notes | Number | 2 | |||||||||||||||||||||||
| Interest rate | 10.00% | |||||||||||||||||||||||
| Due date | Dec. 31, 2017 | |||||||||||||||||||||||
| Terms of conversion feature | The notes provide that the principal and interest on the notes would be convertible to shares of common stock at a conversion rate of $8.25 per share or seventy percent (70%) of the anticipated initial public offering (“IPO”) price per share | |||||||||||||||||||||||
| Debt conversion, principal | $ 25,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | $ 2,186 | |||||||||||||||||||||||
| Interest expense | 76 | 249 | 1,312 | 249 | ||||||||||||||||||||
| Debt conversion converted instrument, shares issued | shares | 7,615 | |||||||||||||||||||||||
| Conversion price | $ / shares | $ 3.57 | |||||||||||||||||||||||
| Loss on extinguishment of debt | $ 18,504 | |||||||||||||||||||||||
| Convertible Note [Member] | Beaufort Capital Partners, LLC [Member] | ||||||||||||||||||||||||
| Convertible promissory note | $ 500,000 | |||||||||||||||||||||||
| Interest rate | 12.00% | |||||||||||||||||||||||
| Due date | Apr. 30, 2016 | |||||||||||||||||||||||
| Terms of conversion feature | The note contained a conversion feature allowing the principal and any unpaid accrued interest to be converted into common shares of the company at a rate of $8.25 or 20% less than the price of the anticipated Initial Public Offering, whichever is less, per share at the discretion of the note holder | |||||||||||||||||||||||
| Convertible Note [Member] | Beaufort Capital Partners, LLC [Member] | Bridge Notes Payable [Member] | ||||||||||||||||||||||||
| Debt conversion, principal | 500,000 | |||||||||||||||||||||||
| Debt conversion, accrued interest | 83,500 | |||||||||||||||||||||||
| Debt conversion converted instrument, bridge notes issued | 490,000 | |||||||||||||||||||||||
| Bridge note payable, payments for points withheld | 10,000 | |||||||||||||||||||||||
| Payments for finder's fee | 25,000 | |||||||||||||||||||||||
| Debt discount | $ 35,000 | |||||||||||||||||||||||
| Accretion of note discount included in interest expense | 12,066 | |||||||||||||||||||||||
| Interest expense | 22,500 | 67,250 | ||||||||||||||||||||||
| Convertible Note [Member] | Warrant [Member] | R. Phillip Zobrist [Member] | ||||||||||||||||||||||||
| Due date | Nov. 12, 2020 | |||||||||||||||||||||||
| Debt discount | $ 824 | |||||||||||||||||||||||
| Accretion of note discount included in interest expense | 14 | 113 | 236 | 337 | ||||||||||||||||||||
| Interest expense | $ 260 | $ 2,125 | $ 4,510 | $ 6,375 | ||||||||||||||||||||
| Common stock shares issuable upon conversion of convertible securities | shares | 4,545 | |||||||||||||||||||||||
| Conversion price, description | Lesser of $11.00 or the offering price of an initial public offering of the Company common stock during the term of the warrant | |||||||||||||||||||||||
| Risk free interest rate | 1.59% | |||||||||||||||||||||||
| Expected life | 5 years | |||||||||||||||||||||||
| Expected volatility | 97.60% | |||||||||||||||||||||||
| Expected dividend yield | 0.00% | |||||||||||||||||||||||
| Share price | $ / shares | $ 0.638 | |||||||||||||||||||||||